Latest Form 4 insider transactions

Brian Charles Walker, a Director of Adi Global Distribution Inc., received 5,825 shares of common stock on August 7, 2026.

Robert B Aarnes, See Remarks and a Director of Adi Global Distribution Inc., reported multiple transactions in common stock on August 7, 2026.

Frederico F. Curado, a Director of Woodward, Inc., received 145 shares of common stock on August 10, 2026.

Michael Carlet, See Remarks of Adi Global Distribution Inc., reported multiple transactions in common stock on August 7, 2026.

Baker Bros. Advisors Lp and 5 others reported changes in beneficial ownership of Replimune Group, Inc. common stock on August 11, 2026.

Franklin Myers, CEO and a Director of HF Sinclair Corp, purchased 15,000 shares of common stock on August 11, 2026 for $85.30 per share.

Albert Chao, Executive Chairman and a Director of Westlake Corp, sold 38,873 shares of common stock on August 11, 2026.

Andrew Stuart, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Bernadette Connaughton, a Director of Halozyme Therapeutics, Inc., sold 1,626 shares of common stock on August 10, 2026 for $102.80 per share.

Karl J Jorgenrud, President, Glob. Industrial of Sherwin Williams Co, sold 7,886 shares of common stock on August 7, 2026 for $368.30 per share.

Alex P Schultz, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Catherine B Reynolds, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Jr. Thomas S. Smith, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Christopher Peetz, CHIEF EXECUTIVE OFFICER and a Director of Mirum Pharmaceuticals, Inc., sold 20,000 shares of common stock on August 10, 2026.

Annette J. Reavis, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Fletcher F Previn, a Director of Celsius Holdings, Inc., received 3,812 shares of common stock on August 7, 2026.

Pamela O. Kaufman, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Raju Prasad, Chief Financial Officer of CRISPR Therapeutics AG, reported a transaction in 750 shares of common stock on August 7, 2026.

Sven-Olof Lindblad, a Director and 10% owner of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Alex R. Thurman, SVP & CHIEF FINANCIAL OFFICER of GLAUKOS Corp, sold 20,000 shares of common stock on August 7, 2026 for $180.13 per share.

John M Fahey Jr, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Jonathan Mayle, SVP, Customer Sales of Honest Company, Inc., sold 79,000 shares of common stock on August 10, 2026 for $5.22 per share.

Joseph Sanborn, CFO and Chief Admin Officer of EverQuote, Inc., sold 6,667 shares of common stock on July 8, 2026 for $25.51 per share.

Mark Ein, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Ryan Fukushima, CEO, Data of Tempus AI, Inc., sold 20,000 shares of common stock on August 7, 2026 for $50.04 per share.

L. Dyson Dryden, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Michael Elliott Bisnow, a Director of Lindblad Expeditions Holdings, Inc., received 3,240 shares of common stock on August 8, 2026.

Sidney J Feltenstein, a Director of Tutor Perini Corp, sold 184,209 shares of common stock on August 7, 2026.

John D. Baker Iii, CEO and a Director of Frp Holdings, Inc., purchased 6,800 shares of common stock on August 7, 2026 for $21.91 per share.

Jeffrey L Radke, Co-Founder, CEO, a Director and 10% owner of Accelerant Holdings, sold 80,000 shares of common stock on August 10, 2026 for $12.09 per share.